EP 1817021 A1 20070815 - NSAID COMPOSITIONS EXHIBITING CLINICAL SUPERIORITY
Title (en)
NSAID COMPOSITIONS EXHIBITING CLINICAL SUPERIORITY
Title (de)
NSAID-ZUSAMMENSETZUNGEN MIT KLINISCHER QUALITÄT
Title (fr)
COMPOSITIONS NSAIS PRESENTANT UNE SUPERIORITE CLINIQUE
Publication
Application
Priority
- CA 2005001687 W 20051103
- US 62480604 P 20041103
Abstract (en)
[origin: WO2006056042A1] The invention is directed to a composition and its use in treating pain, pyrexia and inflammation comprising an NSAIS as the active ingredient, a metasilicate, a first disintegrant and second disintegrant resulting in increased absorption of poorly soluble NSAIS's and increased absorption in suppressed vagal systems. The preferred composition comprises ibuprofen on a metasilicate matrix, sodium bicarbonate as the first disintegrant and tartaric acid as the second disintegrant. The composition may also contain additional pharmaceutically acceptable excipients.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/192 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP)
A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 31/192 (2013.01); A61P 29/00 (2017.12)
Citation (search report)
See references of WO 2006056042A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006056042 A1 20060601; CA 2589079 A1 20060601; EP 1817021 A1 20070815
DOCDB simple family (application)
CA 2005001687 W 20051103; CA 2589079 A 20051103; EP 05850126 A 20051103